Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about CSLLY
Recent news which mentions CSLLY
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
April 26, 2024
Tickers
CSLLY
NEWS
PFE
Tags
News
Large Cap
CSLLY
From
Benzinga
Arcturus Therapeutics' Lung Disease Candidate Triggers Bullish Rating, Analyst Sees Over 200% Upside
December 13, 2023
Tickers
ARCT
CSLLY
Tags
Biotech
Benzinga
Price Target
From
Benzinga
Credit Suisse's $17B Of AT1 Debt Written Down To Zero, Richard Branson's Virgin Orbit Plans Insolvency, Court Freezes Volkswagen's Russian Assets: Today's Top Stories
March 20, 2023
Tickers
BBBY
CS
CSLLY
EADSF
Tags
Market News
MRNA
Markets
From
Benzinga
Large Vaccine Players Including GSK, Moderna Prepare For Bird Flu Vaccine 'Just In Case'
March 20, 2023
Tickers
CSLLY
GSK
MRNA
SNY
Tags
MRNA
Market News
General
From
Benzinga
Travere Therapeutics Scores Accelerated FDA Approval For Rare Kidney Disease Treatment
February 21, 2023
Tickers
CSLLY
LGND
TVTX
Tags
Health Care
Trading Ideas
CSLLY
From
Benzinga
FDA Approves UniQure's Hemgenix, First Hemophilia B Gene Therapy For Adults
November 23, 2022
Tickers
BLUE
CSLLY
QURE
Tags
Biotech
Benzinga
Briefs
From
Benzinga
Why Is Arcturus Therapeutics (ARCT) Stock Up 30% Today?
November 02, 2022
Tickers
ARCT
CSLLY
Tags
ARCT
Market News
NASDAQ:ARCT,OTCMKTS:CSLLY
From
InvestorPlace
Arcturus Shares Jump After Collaboration With CSL For mRNA-Based Vaccines
November 02, 2022
Tickers
ARCT
CSLLY
Tags
why it's moving
Contracts
Market News
From
Benzinga
Travere, CSL's Sparsentan Application Is Under European Review For Rare Kidney Disorder
August 22, 2022
Tickers
CSLLY
TVTX
Tags
Market News
Health Care
CSLLY
From
Benzinga
CSL Posts Encouraging Data From Garadacimab In Severe Swelling Attacks
August 17, 2022
Tickers
CSLLY
Tags
Market News
General
Benzinga
From
Benzinga
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
May 13, 2022
Tickers
BBIO
BFRI
BMY
BTTX
Tags
LGVN
MRNA
PLXP
From
Benzinga
CSL Seals $11.7B Buyout Deal Of Vifor Pharma, Probably the Largest Healthcare Deal In 2021
December 14, 2021
Tickers
CSLLY
GNHAF
GNHAY
MRK
Tags
News
CSLLY
GNHAY
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.